Companion Diagnostics Market Size, Growth, Demands Outlook and Forecasts to 2030

 According to the research report, the global companiondiagnostics market size is expected to touch USD 16.8 Billion by 2030, from USD 8.59 Billion in 2022, growing with a significant CAGR of 8.74% from 2022 to 2030. 

The companion diagnostics market report offers a comprehensive study of the current state expected at the major drivers, market strategies, and key vendors’ growth. The report presents energetic visions to conclude and study the market size, market hopes, and competitive surroundings. The research also focuses on the important achievements of the market, research & development, and regional growth of the leading competitors operating in the market. The current trends of the global companion diagnostics market in conjunction with the geographical landscape of this vertical have also been included in this report.

The report offers intricate dynamics about different aspects of the global companion diagnostics market, which aids companies operating in the market in making strategic development decisions. The study also elaborates on significant changes that are highly anticipated to configure growth of the global companion diagnostics market during the forecast period. It also includes a key indicator assessment that highlights growth prospects of this market and estimates statistics related to growth of the market in terms of value (US$ Mn) and volume (tons).

Sample Link @ https://www.precedenceresearch.com/sample/2457

 Report Scope of the Companion Diagnostics Market

Report Coverage	Details
Market Size in 2022	USD 8.59 Billion
Market Size by 2030	USD 16.8 Billion
Growth Rate from 2022 to 2030	CAGR of 8.74%
Base Year	2021
Forecast Period	2022 to 2030
Segments Covered	By Indication By Product & Service By Technology By Indication By End-User

This study covers a detailed segmentation of the global companion diagnostics market, along with key information and a competition outlook. The report mentions company profiles of players that are currently dominating the global companion diagnostics market, wherein various developments, expansions, and winning strategies practiced and implemented by leading players have been presented in detail.

Key Players

• F. Hoffmann-La Roche Ltd. (Switzerland)
• Agilent Technologies, Inc. (US)
• Qiagen N.V. (Germany)
• Thermo Fisher Scientific, Inc. (US)
• Abbott Laboratories, Inc. (US)

Market Segmentation

 By Indication

• Cancer
  • Lung Cancer
  • Breast Cancer
  • Blood Cancer
  • Colorectal Cancer
  • Other Cancer Types
• Neurological Disorders
• Cardiovascular Diseases
• Infectious Diseases
• Other Indications

By Product & Service

• Assays, Kits & Reagents
• Software & Services

By Technology

• Polymerase Chain Reaction
• Next-generation Sequencing
• In Situ Hybridization
• Immunohistochemistry
• Other

By Indication

• Oncology
• Neurology
• Infectious Diseases
• Others 

By End-User

• Pharmaceutical & Biopharmaceutical Companies
• Reference Laboratories
• Contract Research Organizations
• Other End Users

By Geography

• North America
• Europe
• Asia-Pacific
• Latin America
• Middle East & Africa (MEA)

Research Methodology

The research methodology adopted by analysts for compiling the global companion diagnostics market report is based on detailed primary as well as secondary research. With the help of in-depth insights of the market-affiliated information that is obtained and legitimated by market-admissible resources, analysts have offered riveting observations and authentic forecasts for the global market.

During the primary research phase, analysts interviewed market stakeholders, investors, brand managers, vice presidents, and sales and marketing managers. Based on data obtained through interviews of genuine resources, analysts have emphasized the changing scenario of the global market.

For secondary research, analysts scrutinized numerous annual report publications, white papers, market association publications, and company websites to obtain the necessary understanding of the global companion diagnostics market.

TABLE OF CONTENT

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Companion Diagnostics Market 

5.1. COVID-19 Landscape: Companion Diagnostics Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Companion Diagnostics Market, By Indication

8.1. Companion Diagnostics Market, by Indication, 2022-2030

8.1.1. Cancer

8.1.1.1. Market Revenue and Forecast (2017-2030)

8.1.2. Neurological Disorders

8.1.2.1. Market Revenue and Forecast (2017-2030)

8.1.3. Cardiovascular Diseases

8.1.3.1. Market Revenue and Forecast (2017-2030)

8.1.4. Infectious Diseases

8.1.4.1. Market Revenue and Forecast (2017-2030)

8.1.5. Other Indications

8.1.5.1. Market Revenue and Forecast (2017-2030)

Chapter 9. Global Companion Diagnostics Market, By Product & Service

9.1. Companion Diagnostics Market, by Product & Service, 2022-2030

9.1.1. Assays, Kits & Reagents

9.1.1.1. Market Revenue and Forecast (2017-2030)

9.1.2. Software & Services

9.1.2.1. Market Revenue and Forecast (2017-2030)

Chapter 10. Global Companion Diagnostics Market, By Technology 

10.1. Companion Diagnostics Market, by Technology, 2022-2030

10.1.1. Polymerase Chain Reaction

10.1.1.1. Market Revenue and Forecast (2017-2030)

10.1.2. Next-generation Sequencing

10.1.2.1. Market Revenue and Forecast (2017-2030)

10.1.3. In Situ Hybridization

10.1.3.1. Market Revenue and Forecast (2017-2030)

10.1.4. Immunohistochemistry

10.1.4.1. Market Revenue and Forecast (2017-2030)

10.1.5. Other

10.1.5.1. Market Revenue and Forecast (2017-2030)

Chapter 11. Global Companion Diagnostics Market, By Indication

11.1. Companion Diagnostics Market, by Indication, 2022-2030

11.1.1. Oncology

11.1.1.1. Market Revenue and Forecast (2017-2030)

11.1.2. Neurology

11.1.2.1. Market Revenue and Forecast (2017-2030)

11.1.3. Infectious Diseases

11.1.3.1. Market Revenue and Forecast (2017-2030)

11.1.4. Others

11.1.4.1. Market Revenue and Forecast (2017-2030)

11.1.5. Others

11.1.5.1. Market Revenue and Forecast (2017-2030)

Chapter 12. Global Companion Diagnostics Market, By End-User

12.1. Companion Diagnostics Market, by End-User, 2022-2030

12.1.1. Pharmaceutical & Biopharmaceutical Companies

12.1.1.1. Market Revenue and Forecast (2017-2030)

12.1.2. Reference Laboratories

12.1.2.1. Market Revenue and Forecast (2017-2030)

12.1.3. Contract Research Organizations

12.1.3.1. Market Revenue and Forecast (2017-2030)

12.1.4. Other End Users

12.1.4.1. Market Revenue and Forecast (2017-2030)

Chapter 13. Global Companion Diagnostics Market, Regional Estimates and Trend Forecast

13.1. North America

13.1.1. Market Revenue and Forecast, by Indication (2017-2030)

13.1.2. Market Revenue and Forecast, by Product & Service (2017-2030)

13.1.3. Market Revenue and Forecast, by Technology (2017-2030)

13.1.4. Market Revenue and Forecast, by Indication (2017-2030)

13.1.5. Market Revenue and Forecast, by End-User (2017-2030)

13.1.6. U.S.

13.1.6.1. Market Revenue and Forecast, by Indication (2017-2030)

13.1.6.2. Market Revenue and Forecast, by Product & Service (2017-2030)

13.1.6.3. Market Revenue and Forecast, by Technology (2017-2030)

13.1.6.4. Market Revenue and Forecast, by Indication (2017-2030)

13.1.6.5. Market Revenue and Forecast, by End-User (2017-2030) 

13.1.7. Rest of North America

13.1.7.1. Market Revenue and Forecast, by Indication (2017-2030)

13.1.7.2. Market Revenue and Forecast, by Product & Service (2017-2030)

13.1.7.3. Market Revenue and Forecast, by Technology (2017-2030)

13.1.7.4. Market Revenue and Forecast, by Indication (2017-2030)

13.1.7.5. Market Revenue and Forecast, by End-User (2017-2030)

13.2. Europe

13.2.1. Market Revenue and Forecast, by Indication (2017-2030)

13.2.2. Market Revenue and Forecast, by Product & Service (2017-2030)

13.2.3. Market Revenue and Forecast, by Technology (2017-2030)

13.2.4. Market Revenue and Forecast, by Indication (2017-2030) 

13.2.5. Market Revenue and Forecast, by End-User (2017-2030) 

13.2.6. UK

13.2.6.1. Market Revenue and Forecast, by Indication (2017-2030)

13.2.6.2. Market Revenue and Forecast, by Product & Service (2017-2030)

13.2.6.3. Market Revenue and Forecast, by Technology (2017-2030)

13.2.7. Market Revenue and Forecast, by Indication (2017-2030) 

13.2.8. Market Revenue and Forecast, by End-User (2017-2030) 

13.2.9. Germany

13.2.9.1. Market Revenue and Forecast, by Indication (2017-2030)

13.2.9.2. Market Revenue and Forecast, by Product & Service (2017-2030)

13.2.9.3. Market Revenue and Forecast, by Technology (2017-2030)

13.2.10. Market Revenue and Forecast, by Indication (2017-2030)

13.2.11. Market Revenue and Forecast, by End-User (2017-2030)

13.2.12. France

13.2.12.1. Market Revenue and Forecast, by Indication (2017-2030)

13.2.12.2. Market Revenue and Forecast, by Product & Service (2017-2030)

13.2.12.3. Market Revenue and Forecast, by Technology (2017-2030)

13.2.12.4. Market Revenue and Forecast, by Indication (2017-2030)

13.2.13. Market Revenue and Forecast, by End-User (2017-2030)

13.2.14. Rest of Europe

13.2.14.1. Market Revenue and Forecast, by Indication (2017-2030)

13.2.14.2. Market Revenue and Forecast, by Product & Service (2017-2030)

13.2.14.3. Market Revenue and Forecast, by Technology (2017-2030)

13.2.14.4. Market Revenue and Forecast, by Indication (2017-2030)

13.2.15. Market Revenue and Forecast, by End-User (2017-2030)

13.3. APAC

13.3.1. Market Revenue and Forecast, by Indication (2017-2030)

13.3.2. Market Revenue and Forecast, by Product & Service (2017-2030)

13.3.3. Market Revenue and Forecast, by Technology (2017-2030)

13.3.4. Market Revenue and Forecast, by Indication (2017-2030)

13.3.5. Market Revenue and Forecast, by End-User (2017-2030)

13.3.6. India

13.3.6.1. Market Revenue and Forecast, by Indication (2017-2030)

13.3.6.2. Market Revenue and Forecast, by Product & Service (2017-2030)

13.3.6.3. Market Revenue and Forecast, by Technology (2017-2030)

13.3.6.4. Market Revenue and Forecast, by Indication (2017-2030)

13.3.7. Market Revenue and Forecast, by End-User (2017-2030)

13.3.8. China

13.3.8.1. Market Revenue and Forecast, by Indication (2017-2030)

13.3.8.2. Market Revenue and Forecast, by Product & Service (2017-2030)

13.3.8.3. Market Revenue and Forecast, by Technology (2017-2030)

13.3.8.4. Market Revenue and Forecast, by Indication (2017-2030)

13.3.9. Market Revenue and Forecast, by End-User (2017-2030)

13.3.10. Japan

13.3.10.1. Market Revenue and Forecast, by Indication (2017-2030)

13.3.10.2. Market Revenue and Forecast, by Product & Service (2017-2030)

13.3.10.3. Market Revenue and Forecast, by Technology (2017-2030)

13.3.10.4. Market Revenue and Forecast, by Indication (2017-2030)

13.3.10.5. Market Revenue and Forecast, by End-User (2017-2030)

13.3.11. Rest of APAC

13.3.11.1. Market Revenue and Forecast, by Indication (2017-2030)

13.3.11.2. Market Revenue and Forecast, by Product & Service (2017-2030)

13.3.11.3. Market Revenue and Forecast, by Technology (2017-2030)

13.3.11.4. Market Revenue and Forecast, by Indication (2017-2030)

13.3.11.5. Market Revenue and Forecast, by End-User (2017-2030)

13.4. MEA

13.4.1. Market Revenue and Forecast, by Indication (2017-2030)

13.4.2. Market Revenue and Forecast, by Product & Service (2017-2030)

13.4.3. Market Revenue and Forecast, by Technology (2017-2030)

13.4.4. Market Revenue and Forecast, by Indication (2017-2030)

13.4.5. Market Revenue and Forecast, by End-User (2017-2030)

13.4.6. GCC

13.4.6.1. Market Revenue and Forecast, by Indication (2017-2030)

13.4.6.2. Market Revenue and Forecast, by Product & Service (2017-2030)

13.4.6.3. Market Revenue and Forecast, by Technology (2017-2030)

13.4.6.4. Market Revenue and Forecast, by Indication (2017-2030)

13.4.7. Market Revenue and Forecast, by End-User (2017-2030)

13.4.8. North Africa

13.4.8.1. Market Revenue and Forecast, by Indication (2017-2030)

13.4.8.2. Market Revenue and Forecast, by Product & Service (2017-2030)

13.4.8.3. Market Revenue and Forecast, by Technology (2017-2030)

13.4.8.4. Market Revenue and Forecast, by Indication (2017-2030)

13.4.9. Market Revenue and Forecast, by End-User (2017-2030)

13.4.10. South Africa

13.4.10.1. Market Revenue and Forecast, by Indication (2017-2030)

13.4.10.2. Market Revenue and Forecast, by Product & Service (2017-2030)

13.4.10.3. Market Revenue and Forecast, by Technology (2017-2030)

13.4.10.4. Market Revenue and Forecast, by Indication (2017-2030)

13.4.10.5. Market Revenue and Forecast, by End-User (2017-2030)

13.4.11. Rest of MEA

13.4.11.1. Market Revenue and Forecast, by Indication (2017-2030)

13.4.11.2. Market Revenue and Forecast, by Product & Service (2017-2030)

13.4.11.3. Market Revenue and Forecast, by Technology (2017-2030)

13.4.11.4. Market Revenue and Forecast, by Indication (2017-2030)

13.4.11.5. Market Revenue and Forecast, by End-User (2017-2030)

13.5. Latin America

13.5.1. Market Revenue and Forecast, by Indication (2017-2030)

13.5.2. Market Revenue and Forecast, by Product & Service (2017-2030)

13.5.3. Market Revenue and Forecast, by Technology (2017-2030)

13.5.4. Market Revenue and Forecast, by Indication (2017-2030)

13.5.5. Market Revenue and Forecast, by End-User (2017-2030)

13.5.6. Brazil

13.5.6.1. Market Revenue and Forecast, by Indication (2017-2030)

13.5.6.2. Market Revenue and Forecast, by Product & Service (2017-2030)

13.5.6.3. Market Revenue and Forecast, by Technology (2017-2030)

13.5.6.4. Market Revenue and Forecast, by Indication (2017-2030)

13.5.7. Market Revenue and Forecast, by End-User (2017-2030)

13.5.8. Rest of LATAM

13.5.8.1. Market Revenue and Forecast, by Indication (2017-2030)

13.5.8.2. Market Revenue and Forecast, by Product & Service (2017-2030)

13.5.8.3. Market Revenue and Forecast, by Technology (2017-2030)

13.5.8.4. Market Revenue and Forecast, by Indication (2017-2030)

13.5.8.5. Market Revenue and Forecast, by End-User (2017-2030)

Chapter 14. Company Profiles

14.1. F. Hoffmann-La Roche Ltd. (Switzerland)

14.1.1. Company Overview

14.1.2. Product Offerings

14.1.3. Financial Performance

14.1.4. Recent Initiatives

14.2. Agilent Technologies, Inc. (US)

14.2.1. Company Overview

14.2.2. Product Offerings

14.2.3. Financial Performance

14.2.4. Recent Initiatives

14.3. Qiagen N.V. (Germany)

14.3.1. Company Overview

14.3.2. Product Offerings

14.3.3. Financial Performance

14.3.4. Recent Initiatives

14.4. Thermo Fisher Scientific, Inc. (US)

14.4.1. Company Overview

14.4.2. Product Offerings

14.4.3. Financial Performance

14.4.4. Recent Initiatives

14.5. Abbott Laboratories, Inc. (US)

14.5.1. Company Overview

14.5.2. Product Offerings

14.5.3. Financial Performance

14.5.4. Recent Initiatives

Chapter 15. Research Methodology

15.1. Primary Research

15.2. Secondary Research

15.3. Assumptions

Chapter 16. Appendix

16.1. About Us

16.2. Glossary of Terms

Contact Us:

Precedence Research

Apt 1408 1785 Riverside Drive Ottawa, ON, K1G 3T7, Canada

Call: +1 774 402 6168

Email: sales@precedenceresearch.com

Website: https://www.precedenceresearch.com

 Blog: https://www.pharma-geek.com